Atorvastatin 40 mg
Sponsors
Organon and Co, Ferrer Internacional S.A., HK inno.N Corporation, Rawalpindi Medical College, King Edward Medical University
Conditions
Acute Coronary SyndromesHealthyHypercholesterolemiaHypertensionMi Q WavePulmonary Tuberculosis (TB)
Phase 1
Phase 2
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
NCT02791958
Start: 2016-03-31End: 2017-10-31Target: 528Updated: 2017-04-10
ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
RecruitingNCT07303699
Start: 2026-01-03End: 2028-03-30Target: 80Updated: 2026-01-23
Phase 3
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
CompletedNCT00535405
Start: 2007-11-30End: 2009-03-31Updated: 2024-05-16
Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)
CompletedNCT00782184
Start: 2008-11-30End: 2010-09-30Updated: 2024-05-16
An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)
CompletedNCT03867110
Start: 2000-03-06End: 2001-07-27Updated: 2024-05-10
Phase 4
Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome
CompletedNCT06053983
Start: 2023-01-01End: 2023-08-01Updated: 2023-10-17
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
RecruitingNCT06765265
Start: 2025-01-05End: 2026-01-01Target: 152Updated: 2025-03-11